SCHEMBL3245366

SCHEMBL3245366

C#CCN(CCO)S(=O)(=O)c1ccc2[nH]c(=O)c3[nH]cc(C(=O)O)c3c2c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 16/20 0.39
ALDH1A1 P00352 10/20 0.39
HPGD P15428 8/20 0.39
HSD17B10 Q99714 8/20 0.39
USP2 O75604 2/20 0.39
RXFP1 Q9HBX9 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ADRB2 P07550 1/20 0.37
RECQL P46063 1/20 0.37
POLB P06746 3/20 0.37
MAPT P10636 3/20 0.37
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 2/20 0.34
MAPK1 P28482 1/20 0.34
ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3247255 0.92 RXFP1 (0.42) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL3253590 0.90 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL3248746 0.87 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL3245537 0.87 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL3245166 0.86 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL3250632 0.85 KDM4E (0.38) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL4162646 0.85 KDM4E (0.35) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL3241772 0.84 KDM4E (0.36) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL3250636 0.83 KDM4E (0.38) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL3250592 0.83 HPGD (0.34) KDM4EALDH1A1HPGDHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP claimed
EP-1899335-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2008-03-19 EP claimed
WO-2007003611-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2007-01-11 WO claimed
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP disclosed
EP-1899335-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2008-03-19 EP disclosed
WO-2007003611-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2007-01-11 WO disclosed